KC
PRVB

Kryger Capital’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Kryger Capital’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-754,282
Closed -$18.2M – 24
2023
Q1 		$18.2M Buy
+754,282
New +$9.47M 3.17% 10

Other funds holding PRVB

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Kryger Capital's PRVB Position: Q2 2023 in Review

Kryger Capital sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 754,282 shares — an estimated $18.2M sold.

Kryger Capital first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $18.2M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

  • Kryger Capital reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Kryger Capital sold 754,282 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $18.2M.
  • Kryger Capital first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Kryger Capital's Provention Bio, Inc. Common Stock position peaked at $18.2M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Kryger Capital's 13F filing for Q2 2023, filed 10 Aug 2023.